Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer

BackgroundThe combination of immune checkpoint inhibitors (ICIs) and chemotherapy is known to improve overall survival (OS) in patients with extensive-stage small cell lung cancer (ES-SCLC). ICIs have different response patterns and survival kinetics characteristics from those of the traditional che...

Ful tanımlama

Kaydedildi:

Detaylı Bibliyografya
Asıl Yazarlar:	Shuang Zhang, Shuang Li, Yanan Cui, Peiyan Zhao, Xiaodan Sun, Ying Cheng
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	Frontiers Media S.A. 2021-07-01
Seri Bilgileri:	Frontiers in Oncology
Konular:	small-cell lung cancer surrogate endpoints survival immunotherapy restricted mean survival time (RMST)
Online Erişim:	https://www.frontiersin.org/articles/10.3389/fonc.2021.696010/full
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

Consideration of Surrogate Endpoints for Overall Survival Associated With First-Line Immunotherapy in Extensive-Stage Small Cell Lung Cancer

Benzer Materyaller